Your browser doesn't support javascript.
loading
Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease.
Bes, Cemal; Köybasi, Gizem; Içaçan, Ozan Cemal; Yalçin Mutlu, Melek; Yildirim, Fatih.
Affiliation
  • Bes C; Department of Internal Medicine and Rheumatology, University of Health Sciences, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Köybasi G; Department of Chest Disease, Yedikule Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey.
  • Içaçan OC; Department of Rheumatology, University of Health Sciences, Bakirko¨ y Dr. Sadi Konuk, Training and Research Hospital, Istanbul, Turkey.
  • Yalçin Mutlu M; Department of Internal Medicine and Rheumatology, University of Health Sciences, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Yildirim F; Department of Internal Medicine and Rheumatology, University of Health Sciences, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
Eur J Rheumatol ; 9(3): 176-179, 2022 07.
Article in En | MEDLINE | ID: mdl-35156636
ABSTRACT
Interstitial lung disease (ILD) is one of the common extra-articular manifestations of rheumatoid arthritis (RA) and it is associated with high mortality rate. The usual interstitial pneumonia (UIP) pattern of RA associated ILD (RA-ILD) shows some similarities to idiopathic pulmonary fibrosis, suggesting that antifibrotic therapies may have potential positive affects. In this review, we discuss the effectiveness of antifibrotic therapy for RA-ILD.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Lung Diseases, Interstitial Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Eur J Rheumatol Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Lung Diseases, Interstitial Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Eur J Rheumatol Year: 2022 Document type: Article Affiliation country: